Project
Ongoing
3 Members
Antibody-based anti-tumor immunotherapy
Pierre Bruhns (PI)
Antibody-based anti-tumor immunotherapy that aims at identifying the human FcγRs involved in melanoma and/or breast cancer immunotherapy, and at identifying the effector population(s) responsible for tumor destruction